ATCT-25 LONG-TERM REMISSION OVER 5 YEARS FOR PATIENT WITH RECURRENT GLIOBLASTOMA TREATED WITH CEDIRANIB/LOMUSTINE

Samankaltaisia teoksia

• Long-term Remission Over Six Years for a Patient with Recurrent Glioblastoma Treated with Cediranib/Lomustine
  Tekijä: Drazin, Doniel, et al.
  Julkaistu: (2016)
• ATCT-07 PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-α ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
  Tekijä: Phuphanich, Surasak, et al.
  Julkaistu: (2015)
• ATCT-24 ROLE OF PHOTODYNAMIC THERAPY (PDT) FOR GLIOBLASTOMA
  Tekijä: Nitta, Masayuki, et al.
  Julkaistu: (2015)
• IMCT-12 A PHASE 1 TRIAL OF VACCINATION WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE DERIVED FROM AN ALLOGENEIC GLIOBLASTOMA STEM-LIKE CELL LINE FOR PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA
  Tekijä: Hu, Jethro, et al.
  Julkaistu: (2015)
• Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
  Tekijä: Batchelor, Tracy T., et al.
  Julkaistu: (2013)